These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Lung surfactant in an era of replacement therapy. Notter RH; Shapiro DL Pediatrics; 1981 Dec; 68(6):781-9. PubMed ID: 6275335 [TBL] [Abstract][Full Text] [Related]
43. The circulation, fluid transfers and surface activity in the lungs of infants with hyaline membrane disease. Normand IC Bull Physiopathol Respir (Nancy); 1973; 9(6):1473-94. PubMed ID: 4602246 [No Abstract] [Full Text] [Related]
44. Current concepts on the pulmonary surfactant in infants. Parmigiani S; Solari E; Bevilacqua G J Matern Fetal Neonatal Med; 2005 Dec; 18(6):369-80. PubMed ID: 16390802 [TBL] [Abstract][Full Text] [Related]
46. Respiratory distress syndrome in the tiny baby. Fawcett WA; Gluck L Clin Perinatol; 1977 Sep; 4(2):411-23. PubMed ID: 332436 [No Abstract] [Full Text] [Related]
47. The role of surfactant treatment in preterm infants and term newborns with acute respiratory distress syndrome. Wirbelauer J; Speer CP J Perinatol; 2009 May; 29 Suppl 2():S18-22. PubMed ID: 19399004 [TBL] [Abstract][Full Text] [Related]
50. [Surfactant behavior of the lungs of the newborn. Histological studies of stillborn and premature infants and infants dying of the hyaline membrane disease (respiratory distress syndrome)]. Baum M; Benzer H; Lempert J; Regele H; Stühlinger W; Tölle W Pneumonologie; 1971; 144(3):176-81. PubMed ID: 5171588 [No Abstract] [Full Text] [Related]
51. [Study of the lung surfactant maturity by biochemical and biophysical analyses of gasral aspirates from newborn infants]. Bangyozova M; Jordanova A; Tsanova A; Doumanov J; Christova E; Lalchev Z Akush Ginekol (Sofiia); 2012; 51(4):12-8. PubMed ID: 23234020 [TBL] [Abstract][Full Text] [Related]
53. Surfactant abnormalities in babies dying from sudden infant death syndrome. Morley CJ; Hill CM; Brown BD; Barson AJ; Davis JA Lancet; 1982 Jun; 1(8285):1320-3. PubMed ID: 6123636 [No Abstract] [Full Text] [Related]
54. The influence of surface active substances on alveolar mechanics in the respiratory distress syndrome. Rüfer R Respiration; 1968; 25(6):441-57. PubMed ID: 5687215 [No Abstract] [Full Text] [Related]
55. [The surface tension properties of the lungs of newborn babies. Investigations from autopsies on stillborn and premature infants and babies dying from hyaline membrane disease 'respiratory distress' syndrome]. Baum M; Benzer H; Lempert J; Regele H; Stühlinger W; Tölle W Respiration; 1971; 28(5):409-28. PubMed ID: 5171707 [No Abstract] [Full Text] [Related]
56. [Morphological investigation of the neonatal lung with respiratory distress syndrome which was maximally distended with Somentor 33 and formalin (author's transl)]. Frick R Geburtshilfe Frauenheilkd; 1976 Sep; 36(9):751-9. PubMed ID: 989753 [TBL] [Abstract][Full Text] [Related]
57. Pulmonary surfactant. Dobbs LG Annu Rev Med; 1989; 40():431-46. PubMed ID: 2658759 [TBL] [Abstract][Full Text] [Related]